EV/EBITDA
-2.48
-0.10-4.20%
37 min ago
Summary
- As of February 12, 2025, MLYS EV/EBITDA is -2.48, with a fall of -0.10 (-4.20%) during the most recent trading day.
- Over the past year, MLYS EV/EBITDA has increased by +5.51 (+68.96%).
- MLYS EV/EBITDA is now -26.53% below its all-time high of -1.96.
Performance
MLYS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLYS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -4.2% | +4.3% | +3.5% |
| 1 m1 month | -6.0% | +6.1% | +4.9% |
| 3 m3 months | +26.6% | -26.5% | -22.6% |
| 6 m6 months | +32.8% | -15.8% | -8.7% |
| ytdytd | +18.9% | -18.9% | -15.9% |
| 1 y1 year | +69.0% | -38.2% | -29.5% |
| 5 y5 years | - | - | - |
MLYS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -26.5% | -2.49 | +0.4% | |
| 3 m | 3-month | -1.96 | -26.5% | -3.77 | +34.2% |
| 6 m | 6-month | -1.96 | -26.5% | -4.14 | +40.1% |
| 1 y | 1-year | -1.96 | -26.5% | -8.85 | +72.0% |
| 3 y | 3-year | -1.96 | -26.5% | -22.06 | +88.8% |
| 5 y | 5-year | -1.96 | -26.5% | -22.06 | +88.8% |
| alltime | all time | -1.96 | -26.5% | -22.06 | +88.8% |
Mineralys Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.48(-19.0%) |
| Date | Value |
|---|---|
| 2024 | -3.06(-15.0%) |
| 2023 | -3.60 |
FAQ
- What is Mineralys Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Mineralys Therapeutics?
- What is MLYS EV/EBITDA year-to-date change?
- What is Mineralys Therapeutics EV/EBITDA year-on-year change?
What is Mineralys Therapeutics EV/EBITDA?
The current EV/EBITDA of MLYS is -2.48
What is the all time high EV/EBITDA for Mineralys Therapeutics?
Mineralys Therapeutics all-time high EV/EBITDA is -1.96
What is MLYS EV/EBITDA year-to-date change?
Mineralys Therapeutics EV/EBITDA has changed by +0.58 (+18.95%) since the beginning of the year
What is Mineralys Therapeutics EV/EBITDA year-on-year change?
Over the past year, MLYS EV/EBITDA has changed by +5.51 (+68.96%)